EMA and the Heads of Medicines Agencies (HMA) have published their draft joint EU network strategy to 2028 for an eight-week public consultation. This is a review and update to the original five-year strategy, which...
The European Medicines Agencies Network is updating its five-year strategy, originally covering 2021-2025 (EMANS 2025), to align with goals through 2028 (EMANS 2028). This revised strategy builds on progress from the initial plan and adapts...
EMA has awarded a grant to the African Medicines Regulatory Harmonisation (AMRH) initiative of the African Union Development Agency (AUDA-NEPAD) to support a pilot to test procedures for the joint continental evaluation of medicines in...
Close collaboration between medicines regulators worldwide is paving the way towards the development of a global Pharmaceutical Quality Knowledge Management System (PQ KMS). The goal is to ensure patients can benefit from a continuous supply...
The European Medicines Regulatory Network (EMRN) has been at the forefront of the fight against COVID-19 with its crucial role in the evaluation and monitoring of medicines, including vaccines. A joint report issued by the...
MHRA annual report and accounts 2022 to 2023. Read the press release from Medicines and Healthcare products Regulatory Agency published on 19 July 2023.
The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices and blood components for transfusion in the UK. Read the press release from Medicines and Healthcare products Regulatory Agency published on 4 July 2023.
To assist sponsors and those conducting trials on implementing adequate oversight and monitoring processes for trials of investigational medical products. Read the news from Medicines and Healthcare products Regulatory Agency updated on 28 January 2022.
